Clinical Trial Update: Melphalan, Prednisone, and CC-5013 (Revlimid) as Induction Therapy in Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update summarizes completion of Phase 1 and Phase 2 investigation of induction therapy with melphalan, prednisone, and CC-5013 (Revlimid) in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Melphalan)
• PREDNISONE (Prednisone)
• Revlimid (lenalidomide)

Snippet

Sponsor: University of Turin, Italy | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED